Intrathecal Pumps Market Size

Intrathecal Pumps Market Analysis

The intrathecal pumps market studied is expected to grow with an estimated CAGR of 5.1% over the forecast period

• The COVID-19 pandemic initially impacted the intrathecal pumps market. A 2021 article by the National Center for Biotechnology Information (NCBI) noted that activities related to intrathecal baclofen (ITB) therapy could not be interrupted at the onset of the pandemic due to potentially life-threatening complications. Although patients faced difficulties in reaching medical clinics, a continuation of physical therapy and improvements in anxiety related to medical conditions were observed.
• Despite challenges in communicating with medical staff, optimal scores were maintained at the beginning of the pandemic and one year after without significant differences. Most chronic pain services were classified as non-urgent, and all Intrathecal Pumps (ITP) refill procedures were inadequate or stopped during the pandemic to prevent virus transmission, which impeded market growth. However, services have gradually resumed globally, and the market is expected to grow progressively during the forecast period.
• Major factors driving the growth of Intrathecal pumps are the increasing prevalence of chronic diseases such as cancer pain and other pain-causing procedures such as postoperative pain, where the individual faces continual and severe back pain. Increasing demand for targeted drug delivery systems and technological advancements in intrathecal Pumps is one of the growth drives boosting the market. According to the National Spinal Cord Injury Statistical Center June 2021 report, an estimated 296 thousand people in the United States were living with a spinal cord injury in 2021. Spasticity is the major condition often associated with spinal cord injuries which further increases the demand for intrathecal pumps
• According to International Agency for Research on Cancer (IARC), new estimates on the global cancer burden indicate that by 2040, the number of new cancer cases is said to be around 27.5 million and 16.3 million cancer deaths. Intrathecal pumps are more advantageous than oral therapies because they directly release a drug in the Cerebro Spinal Fluid (CSF) and are absorbed more quickly and directly. Also, the dose of medication required is very less when compared to oral therapies, whereas the pump needs only 1/300 of the drug than oral medication. Increased potency, less systematic exposure, and the bioavailability of the drug are expected to increase the demand for advanced intrathecal pumps.
• In Addition, according to the National Center for Biotechnology Information (NCBI), in 2022, it has been stated that back pain is one of the most common causes of patients seeking emergency care. And some studies have shown that around 23% of adults worldwide suffer from chronic low back pain. This population has also shown a 24% to 80% one-year recurrence rate. Some estimates of lifetime prevalence are as high as 84% in adults. The increasing prevalence of chronic or severe back pain elevates the need for paint management treatment through intrathecal pumps. Hence this is elevating market growth.
• Furthermore, the increase in the geriatric population susceptible to chronic pain has increased the product demand. According to the National Institute on Aging (NIA), the world's senior population will be around 72 million by 2030.
• Therefore, owing to the aforementioned factors, the studied market is anticipated to grow over the analysis period. However, a shortage of awareness regarding pain management and the high product cost is likely to impede market growth.